D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Apple
AAPL
|
+$773M |
| 2 |
Visa
V
|
+$674M |
| 3 |
HES
Hess
HES
|
+$541M |
| 4 |
Mastercard
MA
|
+$448M |
| 5 |
Oracle
ORCL
|
+$419M |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$1.29B |
| 2 |
Advanced Micro Devices
AMD
|
+$979M |
| 3 |
Citigroup
C
|
+$477M |
| 4 |
Exxon Mobil
XOM
|
+$434M |
| 5 |
Booking.com
BKNG
|
+$355M |
Sector Composition
| 1 | Technology | 27.95% |
| 2 | Consumer Discretionary | 14.18% |
| 3 | Financials | 9.99% |
| 4 | Healthcare | 9.55% |
| 5 | Communication Services | 6.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1526
10x Genomics
TXG
$1.57B
| $2.43M | ﹤0.01% |
64,799
+59,855
| +1,211% | +$2.25M |
|
1527
RAPT Therapeutics
RAPT
$268M
| $2.43M | ﹤0.01% |
+33,768
| New | +$2.43M |
|
1528
i3 Verticals
IIIV
$724M
| $2.42M | ﹤0.01% |
105,928
-15,311
| -13% | -$350K |
|
1529
Victoria's Secret
VSCO
$2.12B
| $2.42M | ﹤0.01% |
125,052
+24,880
| +25% | +$482K |
|
|
MODV
1530
DELISTED
ModivCare
MODV
| $2.42M | ﹤0.01% |
103,253
-75,546
| -42% | -$1.77M |
|
1531
Franklin Covey
FC
$240M
| $2.42M | ﹤0.01% |
61,661
+14,207
| +30% | +$558K |
|
1532
Vishay Precision Group
VPG
$416M
| $2.42M | ﹤0.01% |
68,417
-367
| -0.5% | -$13K |
|
1533
NexGen Energy
NXE
$4.36B
| $2.41M | ﹤0.01% |
+310,000
| New | +$2.41M |
|
1534
Arhaus
ARHS
$1.52B
| $2.4M | ﹤0.01% |
156,042
+122,200
| +361% | +$1.88M |
|
1535
WisdomTree India Earnings Fund ETF
EPI
$2.93B
| $2.4M | ﹤0.01% |
55,047
+43,677
| +384% | +$1.9M |
|
1536
Denali Therapeutics
DNLI
$2.07B
| $2.39M | ﹤0.01% |
+116,265
| New | +$2.39M |
|
1537
Nektar Therapeutics
NKTR
$926M
| $2.38M | ﹤0.01% |
169,933
-103,323
| -38% | -$1.45M |
|
1538
Amalgamated Financial
AMAL
$859M
| $2.38M | ﹤0.01% |
99,209
+49,615
| +100% | +$1.19M |
|
1539
Wendy's
WEN
$1.84B
| $2.38M | ﹤0.01% |
126,241
+49,791
| +65% | +$938K |
|
1540
Revolution Medicines
RVMD
$8.7B
| $2.37M | ﹤0.01% |
73,657
+22,584
| +44% | +$728K |
|
1541
AudioCodes
AUDC
$289M
| $2.37M | ﹤0.01% |
181,750
-7,760
| -4% | -$101K |
|
1542
Federal Agricultural Mortgage
AGM
$2.15B
| $2.37M | ﹤0.01% |
12,035
+323
| +3% | +$63.6K |
|
1543
HUTCHMED
HCM
$3.08B
| $2.36M | ﹤0.01% |
140,473
-23,133
| -14% | -$389K |
|
1544
Pathward Financial
CASH
$1.72B
| $2.36M | ﹤0.01% |
46,669
+4
| +0% | +$202 |
|
1545
Camden Property Trust
CPT
$11.7B
| $2.35M | ﹤0.01% |
23,929
-12,252
| -34% | -$1.21M |
|
1546
Colliers International
CIGI
$8.48B
| $2.35M | ﹤0.01% |
+19,241
| New | +$2.35M |
|
1547
iShares US Telecommunications ETF
IYZ
$607M
| $2.35M | ﹤0.01% |
106,785
+94,861
| +796% | +$2.09M |
|
1548
Quetta Acquisition Corp
QETA
| $2.34M | ﹤0.01% |
230,000
| – | – |
|
1549
Varex Imaging
VREX
$469M
| $2.34M | ﹤0.01% |
129,213
-52,459
| -29% | -$950K |
|
1550
Public Service Enterprise Group
PEG
$41.3B
| $2.34M | ﹤0.01% |
35,021
-123,251
| -78% | -$8.23M |
|